Nine Months Later, China Compliance Crackdown No Longer As Feared
This article was originally published in PharmAsia News
Executive Summary
Nearly nine months after the beginning of compliance scandals involving drug makers in China, the international industry appears to have decided the negative impact was not as long-lasting as feared.